Vascular endothelial growth factor-A gene polymorphisms in women with recurrent pregnancy loss

Journal of Reproductive Immunology

Volumn 88, Issue 1, 2011, Pages 48-52

  Eller, Alexandra G ^a,b   Branch, D Ware ^a,c   Nelson, Lesa ^c   Porter, T Flint ^a,c   Silver, Robert M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c Taueret Laboratories   (United States)

Author keywords

Gene polymorphisms; Recurrent pregnancy loss; VEGFA vascular endothelial growth factor A

Indexed keywords

VASCULOTROPIN A;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT ABORTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ABORTION, HABITUAL; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; ETHNIC GROUPS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMANS; PLACENTA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY OUTCOME; PROMOTER REGIONS, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650249178     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2010.06.159     Document Type: Article

References (18)

1. Awata T., Inoue K., Kurihara S., Ohkubo T., Watanabe M., Inukai K., Inoue I., Katayama S. A common polymorphism in the 5′-untranslated region of the VEGFA gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002, 51:1635-1639.
2. Baek K.H. Aberrant gene expression associated with recurrent pregnancy loss. Mol. Hum. Reprod. 2004, 10:291-297.
3. Brogan I.J., Khan N., Isaac K., Hutchinson J.A., Pravica V., Hutchinson I.V. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum. Immunol. 1999, 60:1245-1249.
4. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGFA allele. Nature 1996, 380:435-439.
5. Christiansen O.B., Steffensen R., Nielsen H.S., Varming K. Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol. Obstet. Invest. 2008, 66:257-267.
6. Coulam C.B., Jeyendran R.S. Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss. Am. J. Reprod. Immunol. 2008, 59:301-305.
7. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGFA gene. Nature 1996, 380:439-442.
8. Goodman C., Jeyendran R.S., Coulam C.B. Vascular endothelial growth factor gene polymorphism and implantation failure. Reprod. Biomed. Online 2008, 16:720-723.
9. Jacobs E.J., Feigelson H.S., Bain E.B., Brady K.A., Rodriguez C., Stevens V.L., Patel A.V., Thun M.J., Calle E.E. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res. 2006, 8:R22.
10. Mohammadi M., Froum S., Hamby J.M., Schroeder M.C., Panek R.L., Lu G.H., Eliseenkova A.V., Green D., Schlessinger J., Hubbard S.R. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J. 1998, 17:5896-5904.
11. Mueller M.D., Vigne J.L., Minchenko A., Lebovic D.I., Leitman D.C., Taylor R.N. Regulation of vascular endothelial growth factor (VEGFA) gene transcription by estrogen receptors alpha and beta. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10972-10977.
12. Nybo Andersen A.M., Wohlfahrt J., Christens P., Olsen J., Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000, 320:1708-1712.
13. Papazoglou D., Galazios G., Papatheodorou K., Liberis V., Papanas N., Maltezos E., Maroulis G.B. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil. Steril. 2005, 83:959-963.
14. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J. Vasc. Res. 2000, 37:443-448.
15. Ricketts C., Zeegers M.P., Lubinski J., Maher E.R. Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGFA in familial and sporadic renal cell carcinoma. PLoS One 2009, 4:e6037.
16. Schneider B.P., Radovich M., Sledge G.W., Robarge J.D., Li L., Storniolo A.M., Lemler S., Nguyen A.T., Hancock B.A., Stout M., Skaar T., Flockhart D.A. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res. Treat. 2008, 111:157-163.
17. Shim J.Y., Jun J.K., Jung B.K., Kim S.H., Won H.S., Lee P.R., Kim A. Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women. Am. J. Obstet. Gynecol. 2007, 197(271):e1-e4.
18. Wei P., Yu F.Q., Chen X.L., Tao S.X., Han C.S., Liu Y.X. VEGFA, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey. Placenta 2004, 25:184-196.